Changing myocardial infarction population characteristics: Reasons and implications
Treatment after myocardial infarction: Changes in the last decade - A look back
Treatment of acute myocardial infarction today
Professor Peter Sleight's reflections on the use of β-blocking agents after myocardial infarction
Safety of heart rate-lowering calcium antagonists: Lessons from controlled trials
The place of angiotensin-converting enzyme inhibition after acute myocardial infarction
Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction